olopatadine hydrochloride (Perrigo New York Inc)
Welcome to the PulseAid listing for the olopatadine hydrochloride drug offered from Perrigo New York Inc. This Decreased Histamine Release [PE],Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Perrigo New York Inc |
NON-PROPRIETARY NAME: | Olopatadine Hydrochloride |
SUBSTANCE NAME: | OLOPATADINE HYDROCHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Decreased Histamine Release [PE],Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Inhibitor [EPC] |
ROUTE: | NASAL |
DOSAGE FORM: | SPRAY |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2017-06-14 |
END MARKETING DATE: | 0000-00-00 |
olopatadine hydrochloride HUMAN PRESCRIPTION DRUG Details:
Item Description | olopatadine hydrochloride from Perrigo New York Inc |
LABELER NAME: | Perrigo New York Inc |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 665(ug/1) |
START MARKETING DATE: | 2017-06-14 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 45802-104_8c5cba2a-2fc0-4208-b940-fb288ff9809b |
PRODUCT NDC: | 45802-104 |
APPLICATION NUMBER: | ANDA202853 |
Other OLOPATADINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: